Thermogenesis Holdings Inc
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separa… Read more
Market Cap & Net Worth: Thermogenesis Holdings Inc (THMO)
Thermogenesis Holdings Inc (NASDAQ:THMO) has a market capitalization of $9.51K ($9.51K) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #48088 globally and #14803 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Thermogenesis Holdings Inc's stock price $0.00 by its total outstanding shares 15847500 (15.85 Million).
Thermogenesis Holdings Inc Market Cap History: 2015 to 2024
Thermogenesis Holdings Inc's market capitalization history from 2015 to 2024. Data shows change from $25.97 Billion to $9.51K (-82.50% CAGR).
Thermogenesis Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Thermogenesis Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.01x
Thermogenesis Holdings Inc's market cap is 1.01 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $25.97 Billion | $16.04 Million | -$14.85 Million | 1619.03x | N/A |
| 2016 | $24.60 Billion | $11.93 Million | -$18.59 Million | 2062.47x | N/A |
| 2017 | $21.39 Billion | $14.53 Million | -$29.09 Million | 1472.92x | N/A |
| 2018 | $1.90 Billion | $9.67 Million | -$39.72 Million | 196.79x | N/A |
| 2019 | $3.14 Billion | $13.05 Million | -$9.50 Million | 240.50x | N/A |
| 2020 | $1.49 Billion | $9.74 Million | -$16.35 Million | 152.96x | N/A |
| 2021 | $720.27 Million | $9.29 Million | -$11.38 Million | 77.50x | N/A |
| 2022 | $50.71 Million | $10.48 Million | -$11.27 Million | 4.84x | N/A |
| 2023 | $9.52 Million | $9.45 Million | -$17.98 Million | 1.01x | N/A |
Competitor Companies of THMO by Market Capitalization
Companies near Thermogenesis Holdings Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Thermogenesis Holdings Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Thermogenesis Holdings Inc Historical Marketcap From 2015 to 2024
Between 2015 and today, Thermogenesis Holdings Inc's market cap moved from $25.97 Billion to $ 9.51K, with a yearly change of -82.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $9.51K | -99.90% |
| 2023 | $9.52 Million | -81.22% |
| 2022 | $50.71 Million | -92.96% |
| 2021 | $720.27 Million | -51.67% |
| 2020 | $1.49 Billion | -52.50% |
| 2019 | $3.14 Billion | +64.86% |
| 2018 | $1.90 Billion | -91.10% |
| 2017 | $21.39 Billion | -13.04% |
| 2016 | $24.60 Billion | -5.27% |
| 2015 | $25.97 Billion | -- |
End of Day Market Cap According to Different Sources
On Dec 22nd, 2025 the market cap of Thermogenesis Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.51K USD |
| MoneyControl | $9.51K USD |
| MarketWatch | $9.51K USD |
| marketcap.company | $9.51K USD |
| Reuters | $9.51K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.